āagmanLoginNot investment advice. Data and computed figures, for information only.
Jupiter Life Line Hospitals Ltd
₹239.65
−₹2.35 (−0.97%)
NSE · 15 Oct 2026, close
Market Cap
₹8,709 Cr
CMP
₹239.65
52-wk High / Low
₹1,625 / 235
P/E
45.6
P/B
5.7
Book Value
₹47.1
Div Yield
0.08%
ROCE
15.0%
ROE
13.1%
Face Value
₹2
D/E
0.38
Price−84.2% over 1Y
āagman read
Computed by āagmanPiotroski F-Score
4
/ 9
4 of 9 F-score tests passed
Graham Number
₹79
√(22.5 × EPS × book value per share)
ROIC
8.9%
vs 11.2% sector median
Cash flow to profit
1.38
CFO / PAT
Above 1.0 = operating cash flow exceeded reported profit
Margin change
−287
bps OPM YoY
Operating margin vs the same quarter last year
Sustainable growth
12.6%
ROE × earnings retention ratio
ROE stability
2.6
pp σ
Standard deviation of ROE across periods. Lower = more stable
Holder deltas
QoQ
pp
Prom +0.00FII +0.89DII −0.50
Latest quarter vs the previous one
Cash-accrual divergence
−3.5%
of assets
Low = accruals track cash flow
Strengths
+PE of 45.6x is below the sector median of 45.9x
Watch-outs
−Latest ROCE of 15% trails the sector median of 17%
−Price trades below its 200-day moving average (0.2x)
−Price is 85.3% below its 52-week high
−Annualised volatility of 159.8% is in the high band (≥45%)
Peer comparison
| Name | P/E | Mar Cap ₹ Cr | ROCE % | ROE % |
|---|
Quarterly results
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 243 | 263 | 273 | 291 | 289 | 335 | 333 | 337 | 353 | 394 | 365 | 388 | 411 |
| Expenses | 190 | 202 | 211 | 228 | 223 | 257 | 256 | 257 | 275 | 301 | 282 | 299 | 332 |
| Operating Profit | 53 | 61 | 62 | 63 | 65 | 78 | 76 | 80 | 78 | 92 | 83 | 89 | 79 |
| OPM % | 21.8% | 23.2% | 22.7% | 21.6% | 22.5% | 23.3% | 22.8% | 23.7% | 22.1% | 23.4% | 22.7% | 22.9% | 19.2% |
| Other Income | 4 | 3 | 8 | 10 | 7 | 7 | 7 | 7 | 13 | 11 | 3 | 11 | 11 |
| Interest | 12 | 12 | 1 | 1 | 1 | 1 | 3 | 6 | 8 | 8 | 8 | 9 | 13 |
| Depreciation | 11 | 11 | 11 | 10 | 11 | 14 | 14 | 18 | 21 | 21 | 22 | 23 | 26 |
| Profit before tax | 34 | 41 | 58 | 62 | 60 | 70 | 67 | 63 | 62 | 74 | 57 | 68 | 51 |
| Net Profit | 54 | 34 | 44 | 45 | 45 | 52 | 52 | 45 | 44 | 57 | 42 | 50 | 38 |
| EPS (₹) | 1.91 | 1.03 | 1.33 | 1.37 | 1.36 | 1.58 | 1.59 | 1.38 | 1.34 | 1.75 | 1.30 | 1.53 | 1.14 |
Profit & Loss
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|
| Sales | 463 | 486 | 733 | 893 | 1,073 | 1,302 | 1,500 | 1,558 |
| Expenses | 379 | 419 | 580 | 691 | 831 | 999 | 1,156 | 1,214 |
| Operating Profit | 84 | 67 | 153 | 201 | 242 | 303 | 343 | 344 |
| OPM % | 18.1% | 13.8% | 20.9% | 22.5% | 22.6% | 23.3% | 22.9% | 22.1% |
| Other Income | 0 | 4 | 4 | 8 | 22 | 25 | 37 | 35 |
| Interest | 26 | 39 | 44 | 42 | 26 | 11 | 33 | 37 |
| Depreciation | 26 | 31 | 36 | 39 | 42 | 57 | 88 | 93 |
| Profit before tax | 33 | 2 | 77 | 129 | 195 | 261 | 260 | 249 |
| Net Profit | 30 | −2 | 51 | 73 | 177 | 194 | 194 | 188 |
| EPS (₹) | 1.17 | −0.09 | 2.01 | 2.58 | 5.39 | 5.89 | 5.92 | 5.72 |
Balance Sheet
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 51 | 51 | 51 | 57 | 66 | 66 | 66 | — |
| Reserves | 186 | 188 | 243 | 309 | 1,103 | 1,291 | 1,479 | — |
| Borrowings | 272 | 426 | 495 | 469 | 0 | 393 | 584 | — |
| Other Liabilities | 94 | 124 | 120 | 151 | 112 | 168 | 235 | — |
| Total Liabilities | 603 | 789 | 909 | 986 | 1,281 | 1,917 | 2,363 | — |
| Fixed Assets | 435 | 630 | 684 | 720 | 718 | 978 | 1,384 | — |
| CWIP | 10 | 26 | 27 | 29 | 74 | 185 | 129 | — |
| Investments | 2 | 7 | 3 | 2 | 17 | 507 | 486 | — |
| Other Assets | 156 | 126 | 195 | 235 | 473 | 247 | 364 | — |
| Total Assets | 603 | 789 | 909 | 986 | 1,281 | 1,917 | 2,363 | — |
Cash Flows
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 74 | 123 | 137 | 176 | 115 | 267 | 268 |
| Cash from Investing Activity | −43 | −295 | −84 | −94 | −246 | −497 | −442 |
| Cash from Financing Activity | −32 | 184 | 32 | −51 | 128 | 297 | 136 |
| Net Cash Flow | −1 | 12 | 85 | 31 | −3 | 66 | −38 |
Ratios
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| ROCE % | — | 7.0 | 17.0 | 21.0 | 22.0 | 18.0 | 15.0 |
| ROE % | — | — | — | — | — | — | 13.1 |
| EPS (₹) | 1.17 | −0.09 | 2.01 | 2.58 | 5.39 | 5.89 | 5.92 |
| Book Value (₹) | — | — | — | — | — | — | 47.1 |
| Face Value (₹) | — | — | — | — | — | — | 2 |
| P/E | — | — | — | — | — | — | 45.6 |
| Div Yield % | — | — | — | — | — | — | 0.08 |
| NPM % | 6.5 | −0.4 | 6.9 | 8.1 | 16.2 | 14.6 | 12.6 |
| OPM % | 18.0 | 14.0 | 21.0 | 23.0 | 23.0 | 23.0 | 23.0 |
| D/E | 1.15 | 1.78 | 1.68 | 1.28 | 0.00 | 0.29 | 0.38 |
| P/B | — | — | — | — | — | — | 5.7 |
Growth
Compounded sales growth
5 years+25.0%
3 years+19.0%
TTM+15.0%
Compounded profit growth
5 years+143.0%
3 years+37.0%
TTM−1.0%
Stock price CAGR
3 years+6.0%
Last year−12.0%
Return on equity
5 years17.0%
3 years16.0%
Last year13.0%
Documents
Announcements
Closure of Trading WindowAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAnnouncement under Regulation 30 (LODR)-Earnings Call TranscriptAnnouncement under Regulation 30 (LODR)-Newspaper PublicationAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeCorporate actions
24 Jul 2026SPLITFace Value Split (Sub-Division) - From Rs 10/- Per Share To Rs 2/- Per Share10 : 2
22 May 2026DIVIDENDInterim Dividend - Re 1 Per Share—
4 Jul 2025DIVIDENDDividend - Re 1 Per Share—
2 Aug 2024DIVIDENDDividend - Re 1 Per Share—
Fundamentals from a third-party compiler of exchange filings; prices from the exchanges. Not investment advice.© 2026 āagman